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Abstract 
 
Bacground/Aim. Preterm birth is defined as a delivery 
prior to the completed 37th week of gestation. Literature 
data suggested that periodontal processes may influence to 
the feto-placental unit and induce preterm delivery. The de-
gree of the periodontal disease is influenced by secretor sta-
tus. Pro-inflammatory cytokines are involved in periodonti-
tis as well as in delivery. The combined influence of these 
factors on the risk of preterm birth has not been explored. 
The aim of our study was to investigate the associations be-
tween periodontal diseases, secretor status, and interleukin-
1-β (IL1-ß) and prostaglandine E2 (PGE2) levels in women 
delivered preterm. Methods. The study included 56 pre-
term delivery women and 56 women delivered at term as a 
control group, aged between 17 and 41 years. Periodontal 
examination, blood and saliva sampling were performed 
within 48 hours following delivery. Secretor phenotype was 
determined by hemagglutination inhibition method. The 
concentrations of IL1-ß and PGE2 were measured by high 
sensitivity Enzyme-linked Immunosorbent Assay (ELISA). 
Results. In the pre-term birth group there were 66.1% of 
women with periodontitis, while in the control one there 
were 12.5% (p < 0.01). Concentrations of IL1-ß and PGE2 
in plasma were significantly higher in the non-secretor 
group of women who gave birth pre-term and had perio-
dontitis comparing to other groups. There was a significant 
correlation between salivary and plasma levels of PGE2 and 
IL1-ß in the preterm birth group (R = 0.416, p = 0.017 and 
R = -0.592, p < 0.001, respectively). There were no such 
correlations in women who delivered at term. Conclusion. 
Our results support the hypothesis that non-secretor phe-
notype and periodontitis are at least in part responsible for 
pathogenesis of preterm birth. This probability of negative 
impact of non-secretor status cannot be ignored. These 
findings support the need for additional research into the 
biology of human parturition. 
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Apstrakt 
 
Uvod/Cilj. Prevremeni porođaj se definiše kao porođaj pre 
navršene 37 nedelje gestacije. Podaci iz literature govore u 
prilog tome da periodontalni procesi mogu uticati na feto-
placentalnu jedinicu i indukovati preterminski porođaj. Sek-
retorni status može uticati na stepen periodontalne bolesti. 
Proinflamatorni citokini imaju uticaj na periodontitis kao i 
na porođaj. Kombinovani uticaj ovih faktora rizika za pre-
vremeni porođaj nije dovoljno istražen. Cilj ove studije je 
bio da istraži povezanost između periodontalne bolesti, sek-
retornog statusa, nivoa interleukina 1-β (IL1-ß) i pros-
taglandina E2 (PGE2) kod žena koje su imale prevremeni 
porođaj. Metode. Studijom je bilo obuhvaćeno 56 žena, 
koje su imale prevremen porođaj i 56 žena u kontrolnoj 
grupi koje su se porodile u terminu, starosti između 17 i 41 
godine. Periodontalni pregled, uzorkovanje krvi i salive je 
izvršeno u prvih 48 sati po porođaju. Sekretorni status je 
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određen metodom inhibicije hemaglutinacije. Koncentracije 
IL1-ß i PGE2 su merene visoko senzivinim Enzyme-linked 
Immunosorbent Assay (ELISA) testom. Rezultati. U grupi 
prevremenih porođaja bilo je 66,1% žena sa periodontiti-
som, a u kontrolnoj grupi 12,5% (p < 0.01). Prevremeno 
porođene žena, nesekretori sa periodontitisom imale su u 
plazmi značajno više vrednosti IL 1-ß i PGE 2 u odnosu na 
ostale grupe (p < 0,01). U grupi prevremeno porođenih žena 
postojala je značajna korelacija između salivarnih i plazmat-
skih koncentracija PGE2 i IL1-ß (R = 0.416, p = 0.017 i 
R = -0,592, p < 0,001, redom). Ove korelacije nisu postojale 
kod žena koje su imale terminski porođaj. Zaključak. Naši 
rezultati podržavaju hipotezu da su sekretorni status i perio-
dontitis, bar delimično, odgovorni za patogenezu pretermin-
skog porođaja. Verovatnoća negativnog uticaja nesekretor-
nog statusa se ne sme ignorisati. Ovi zaključci ukazuju na 
potrebu za dodatnim istraživanjima porođaja.  
 
Ključne reči: 
porođaj, prevremeni; periodontitis; interleukin-1beta; 
dinoproston; pljuvačka; plazma. 
 
Introduction 
Preterm birth (PTB) is defined as a delivery prior to the 
completed 37th week of gestation 1. Two-thirds of PTBs are 
spontaneous. The global prevalence rate of preterm birth is 
ranging from 5% to 13.3% 2. PTB is the leading cause of per-
inatal morbidity and mortality. PTB is associated with multi-
ple pathological processes such as medical conditions of the 
mother or fetus, multiple pregnancies, genetic influences, 
male fetus, environmental exposure, infertility treatments, 
behavioral and socioeconomic factors, and iatrogenic prema-
turity 3. Intra-amniotic infection has been causally linked to 
PTB. Intra-amniotic infection induces the production of pro-
inflammatory cytokines involved in term delivery, including 
tumor necrosis factor-alpha (TNF-α), interleukin (IL)-8, 
IL-6, IL-1β, and prostaglandine E2 (PGE2). In some cases of 
PTB microorganisms cannot be detected by cultivation and 
other microbiology techniques despite high levels of cyto-
kines in amniotic fluid. Literature data suggest that in cases 
of PTB with sterile intra-amniotic inflammation, cytokines 
are produced in distant part of the body due to infection and 
inflammation, cross the placental barrier, and when they 
reach appropriate quantities stimulate labor 4. This statement 
is in accordance with Miller’s focal infection theory pub-
lished in 1891 5. 
Microbiological, immunological and animal model 
studies suggested that periodontal processes may influence to 
the feto-placental unit and induce preterm delivery (PTD) 6. 
Periodontal diseases 
Periodontal diseases are infectious diseases that result in 
the inflammation of the specialized tissues that both surround 
and support the teeth. Diseases are multifactorial and they are in-
itiated by bacterial colonization of the dentogingival environ-
ment, sustained by the presence of dental biofilm and host im-
mune defense 7. According to the Armitage 8, there are two ma-
jor categories of periodontal diseases: gingivitis – non-
destructive and reversible gingival inflammation, and periodon-
titis – destructive inflammation of teeth supporting tissues 8. 
Gingivitis 
Gingivitis is a reversible and nondestructive gingival in-
flammation related to a non-specific bacterial challenge. 
Dental plaque is the principal etiologic factor in gingivitis. It 
is characterized by inflammation, edema, erythema and 
bleeding of the gingival marginal portion. Studies reported 
prevalence of gingivitis in around 80% children and adoles-
cents. Gingivitis is, therefore, the form of periodontal disease 
most commonly found. Among pregnant women incidence 
of gingivitis is even greater. Based on clinical observation, 
the frequency of gingivitis in pregnant women ranges from 
35% to 100%. This variation may be a reflection of both the 
population studied and the clinical parameters used 9. Hor-
monal changes during pregnancy influence periodontal tis-
sues through different mechanisms and alter maternal im-
mune response 7. Increased circulating levels of progesterone 
in pregnancy can cause dilatation of gingival capillaries, in-
creased capillary permeability, and gingival exudate. The on-
set of increased gingival inflammation observed in the sec-
ond month of gestation, peaks in the eighth month, and coin-
cides with an increase in the circulating levels of hormones. 
Prostaglandin concentration within the gingiva and gingival 
fluid also increases dramatically with the occurrence of gin-
gival inflammation. When gingivitis is persistent, it can fur-
ther leading to periodontitis 7, 9. 
Periodontitis 
Periodontitis (PD) is a destructive inflammatory disease 
of the supporting tissues of the teeth initiated by polymicro-
bial biofilm. PD is a result of a chronic immune and inflam-
matory response following infection with a complex micro-
biome 10. Typical for the disease is formation of periodontal 
pockets and a chronic destructive inflammation which im-
pacts the whole organism. Synergistic relationship between 
periodontal pathogens and their endotoxins induces chronic 
oral infection; enhance humoral immune response and pro-
duction of inflammatory markers 10. Pro-inflammatory cyto-
kines (IL-1β, IL-6, and TNF-α) and prostaglandins (pros-
taglandine 1 – PGE1 and PGE2) are produced in response to 
infection 11. Vascular permeability is also increased – allow-
ing the diffusion of cytokines into the blood flow which may 
have systemic effects on the host. During the second and 
third trimester of pregnancy, the gingival/periodontal in-
flammation often becomes more severe 9. Published data 
show that cytokines produced in periodontal tissues are ena-
bling to promote inflammation in feto-placental unit 12. 
Analysis of amniotic fluid obtained at the time of preterm 
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birth without chorio-amnionitis shows elevated levels of in-
flammatory cytokines 13. Maternal periodontal infections 
provide a chronic reservoir of inflammatory mediators and 
cytokines (TNF-α, IL-1, IL-6, and PGE2) that could ad-
versely affect pregnancy outcome 14. 
According to literature data, degree of periodontal in-
flammation correlates with cytokines levels 15. Furthermore, 
it has been shown that the degree of the periodontal disease 
is influenced by secretor status 16, 17. 
Secretor status 
The secretor status is regulated by the fucosyltransferase2 
(FUT2) gene. Individuals who express blood group antigens on 
cells surface, and in the saliva and other body fluids are termed 
secretors. Blood group antigens in non-secretors are present on 
cells surface but not in body fluids. Blood group antigens are ol-
igosaccharides. Blood group substances in secretors body fluids 
(A, B, H, Lewis b, Lewis y) are glycoproteins. In saliva the 
blood reactive antigens are found primarily on mucins. Blood 
type antigens and other oligosaccharides act as receptors for 
bacterial adhesion and regulate the oral bacteria – oral micro-
biome. Binding of pathogens to these receptors activates a dis-
tinct signaling pathway that shapes the immune response. There-
fore, secretor/non-secretor phenotypes are associated with some 
metabolic and infectious diseases. Recent evidence suggests that 
non-secretors are at increased risk of carrying some pathogenic 
microorganisms in their body 18. In accordance with these data, 
non-secretors are at increased risk of inflammatory diseases, 
pre-cancerous and cancerous lesions along with periodontitis 19. 
Overall, the study findings are inconsistent and the 
combined influence of these factors on the risk of PTB has 
not been explored. 
Given the established link between periodontitis and se-
cretor status as well as the association between inflammatory 
mediators, periodontitis, and preterm birth we hypothesized 
that in some instances PTB risk could be associated with the 
co-occurrence of increased cytokine levels and secretor sta-
tus in women with periodontitis. More specifically, elevated 
levels of IL-1 ß and PGE2 occur in combination with non-
secretor status. 
Therefore, the purpose of our study was to investigate 
the associations between periodontal diseases, secretor sta-
tus, and IL-1 ß and PGE2 levels and risk of PTB. 
Methods 
This study included 112 women (56 preterm delivery 
women and 56 women that delivered at term as a control) 
aged between 17 and 41 years. Women were enrolled from 
August 2012 to March 2014. All women had their delivery in 
the Clinic for Gynecology and Obstetrics, Clinical Center of 
Serbia in Belgrade. 
The study was conducted after obtaining approval from 
the Ethical Committee of the Faculty of Medicine, Univer-
sity of Belgrade and the Clinical Center of Serbia. Written 
informed consent from all the participants were obtained in 
accordance with the Helsinki Declaration, revised in 2000. 
Blood sampling, saliva sampling, and periodontal exami-
nation were performed within 48 hours following delivery. Ran-
dom sample of control mothers was selected from the birth reg-
ister simultaneously as the cases. Only mothers with a singleton 
gestation were included in the study. Data for mothers and new-
borns were collected from medical records. 
Gestational age was estimated by the last menstrual pe-
riod and ultrasound examination. 
Delivery prior to complete 37 weeks of gestation was 
considered as PTB. 
Exclusion criteria included the following: multiple 
pregnancies, assisted reproductive technique, fetal congenital 
disease, diabetes, preeclampsia, intra-amniotic infection dur-
ing pregnancy and clinical signs of infection (body tempera-
ture over 38°C). 
Blood and saliva sampling were performed just before 
periodontal examinations. 
Blood sampling  
A 4-mL of venous blood samples from antecubital fossa 
were collected in EDTA Vacutainer® tube (Becton Dickin-
son, UK). Blood samples were centrifuged at 3000 rpm for 
15 min and the plasma was aliquoted. The plasma samples 
were frozen at -70C until further analysis. The remaining 
content of tube was used for blood group determination. 
Salivary sampling 
Unstimulated whole saliva was collected in 10 mL glass 
tubes. No antiseptic mouth rinse was used prior to collection. 
Collected saliva samples were centrifuged within 1 hour of 
collection at 3,500 rpm for 20 min at 4°C to obtain a cleared 
supernatant. Two thirds of supernatant were aliquoted, and 
stored at -70°C for further ELISA testing. The remaining 
amount of saliva samples was incubated in boiling water 
bath during 10 min, centrifuged (at 3,500 rpm for 10 min), 
and supernatant was separated and stored at -20°C for further 
secretor status testing. 
Periodontal examination 
The full-mouth periodontal measurements were per-
formed in six sites per tooth by one same experienced exam-
iner. Periodontal measurements include following periodon-
tal clinical parameters: Probing Depth (PD), Clinical At-
tachment Level (CAL), Bleeding on Probing (BOP), Visible 
Plaque Accumulation (PI). According to the classification of 
periodontal diseases, periodontal status was defined as: 
healthy periodontium, gingivitis, and periodontitis 20.  
Determination of blood group and secretor status 
ABO and Rh blood groups were determined in fresh blood 
ethylenediaminetetracetic acid (EDTA)-samples by standard 
hemagglutination methods 21. Red blood cells were suspended in 
a 2–3% (v/v) saline solution; 50 uL of this suspension was 
mixed in tubes with 50 uL of specific antisera, then incubated 
Page 250 VOJNOSANITETSKI PREGLED Vol. 77, No 3 
Nikolić Lj, et al. Vojnosanit Pregl 2020; 77(3): 247–255. 
for 10 min at room temperature, and the results were read by 
naked eye after centrifugation at 2,000 rpm for 1 min. 
Secretor and non-secretor phenotypes were evaluated by 
boiled saliva samples using the Hemagglutination Inhibition As-
say test 21. For each patient 3 tubes were prepared; 50 uL of 
boiled saliva samples was mixed with 50 uL diluted commercial 
antisera (anti-A, anti-B, and anti-H); tubes were incubated for 10 
minutes at room temperature, after that, 50 μL of corresponding 
erythrocytes (A, B, O) were added to the test mixture and all the 
test tubes were agitated and left at room temperature for another 
10 minutes. Results were read by naked eye after centrifugation 
at 2,000 rpm for 1 min. Negative reaction for agglutination is in-
terpreted as positive for secretor status. Positive reaction for ag-
glutination means a negative test which has proven that the per-
son is non-secretor. 
The commercial antisera used for determination of blood 
groups and secretor status were the following: 1) monoclonal 
anti-A, anti-B, anti-AB, and anti-D (Lorne, UK) and 2) Anti-H 
lectin (CE Immunodiagnostics, Germany). All assays included 
appropriate known controls. Each aliquot of saliva and blood 
samples was used only once in an assay, and then discarded. 
Determination of IL-1ß and PGE2 
The concentrations of IL-1ß and PGE2 were measured 
by commercially available high sensitivity enzyme-linked 
immunosorbent assay (ELISA) eBioscience kits, Vienna, 
Austria, and EIA kit Enzo Life Science, Germany. The mi-
croplates were read according to the manufacturer’s recom-
mended time frame using an automated plate reader: Sunrise, 
Tecan Dorset, UK. 
Statistical analysis  
Numerical data were presented as mean ± standard devia-
tion (SD) for normaly distributed data or median with interquar-
tile range for non-normaly distributed data, while categorical 
variables were presented as frequencies or percentages. Distri-
bution of periodontal status among PTB and FTB groups was 
assessed using Fisher's exact test. Inter-group comparisons of 
age, and biochemical parameters was performed using Mann-
Whitney test. Depending on the data types, differences between 
independent samples were assessed using χ2-test, Fisher test, 
Student’s t-test, Kruskal-Wallis, Mann-Whitney U test, while 
differences between the related groups were examined by Wil-
coxon test. The correlations between clinical parameters and la-
boratory parameters as well as between saliva and plasma levels 
of biomarkers amongst PTB and FTB were tested with the 
Spearman's rank correlation test. The statistical analysis was 
performed using commercial software SPSS 20.0, Inc., Chicago, 
IL; p values < 0.05 were considered to be significant.  
Results 
The demographic and clinical characteristics of patients who 
gave preterm birth and full term birth are displayed in Table 1. 
 
Table 1 
Demographic and clinical characteristics of patients with preterm and term delivery 
Parameter Preterm birth n = 56 
Term birth 
n = 56 p 
Maternal age (years), mean ± SD 30.7 ± 5.5 27.0 ± 3.9 ns 
Maternal (ABO) blood type, n (%):    
 O 16 (28.6) 14 (25.0) ns 
 A 24 (42.8) 28 (50.0) ns 
 B 14 (25.0) 12 (21.4) ns 
 AB 2 (3.6) 2 (3.6) ns 
Maternal RhD factor, n (%):    
 positive  46 (82.1) 50 (89.3) ns 
 negative 10(17.9) 6 (10.7) ns 
Maternal secretory status, n (%):    
 secretor  44 (78.6) 44 (78.6) ns 
 non-secretor 12 (21.4) 12 (21.4) ns 
Gingival status, n (%):    
 healthy periodontium 4 (7.1) 31 (55.3) < 0.001 
 gingivitis 15 (26.8) 18 (32.1) ns 
 periodontitis 37 (66.1) 7 (12.5) < 0.001 
Infant gender, n (%):    
 female 24 (42.8) 34 (60.7) < 0.05 
 male 32 (57.2) 22 (39.3) < 0.01 
Infant birth length (cm) mean ± SD 44.96 ± 3.1 50.68 ± 1.2 < 0.05 
Infant birth weight (g) mean ± SD 1862 ± 381 3300 ± 208 < 0.01 
Apgar score, mean ± SD 8.02 ± 1.5 9.02 ± 0.1 < 0.01 
Apgar score 9–10/1 min 32 (57.2) 56 (100) < 0.01 
Apgar score < 7/1 min 5 (8.9) 0 (0) < 0.01 
Parity    
 primiparous 35 (62.5) 34 (60.7) ns 
 multiparous 21 (37.5) 22 (39.3) ns 
SD – standard derviation; ns – non significant. 
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Table 2 
Number of secretors and non-secretors women according to their periodontal status 
Periodontal status, n (%) Secretor status 
healthy periodontium gingivitis periodontitis 
Non-secretor  4 (11.4) 6 (18.2) 14 (31.8)* 
Secretor 31 (88.6) 27 (81.8) 30 (68.2)* 
*Chi-square test, χ2 = 5.00; p < 0.05. 
 
 
Table 3 
Number of subjects in the preterm birth (PTB) and full term birth (FTB) groups according to the periodontal  
and secretory status 
Periodontal status 
PTB 
secretors 
n (%) 
PTB 
non-secretors  
n (%) 
FTB 
secretors 
n (%) 
FTB 
non-secretors  
n (%) 
Periodontitis 27 (61.4) 10 (83,3)* 3 (6.8) 4 (33.3) 
Gingivitis  14 (29.5) 2 (16.7) 14 (31.8) 4 (33.3) 
Healthy periodontium 4 (9.1) 0 (0.0) 27 (61.4)* 4 (33.3) 
*Chi-square test, χ2= 43.6; p < 0.001. 
 
 
Table 4 
Inflammation markers and basic hematological parameters in the preterm and term birth subgroups 
Parameter 
Preterm birth 
Median (25th–75th percentile) 
Full term birth 
Median (25th–75th percentile) 
p 
IL-1ß, sal (pg/mL) 10.837 (9.882–11.570) 11.778 (5.690–12.094) ns 
IL-1ß, pl (pg/mL) 0.0125 (0.0115–0.0141) 0.0099 (0.0075–0.0133) < 0.01 
PGE2, sal (pg/mL) 279 (62–567) 327 (215–423) ns 
PGE2, pl (pg/mL) 967 (107–1267) 461(36.1–1600) < 0.01 
hsCRP, pl (mg/L) 20.4 (7.43–36.7) 19.0 (8.4–47.6) ns 
WBCx109/L 15.2 (13.4–16.8) 15.6 (12.7–18.2) ns 
Hb (g/L) 112 (95.6–118) 111 (101–122) ns 
Plt x109/L 204 (202–265) 218 (201–293) ns 
sal – saliva; pl – plasma; WBC – white blood cells; Hb – hemoglobin; Plt – platelets;  
IL-1β – interleukin-1β; PFE2 – prostaglandine E2; hsCRP – high sensitivity C-reactive protein; ns – non significant. 
 
 
Tested groups were homogenous comparing to age and parity. 
ABO and Rh representation as well as secretor status did not show 
the difference between the tested group and the control. 
In the entire research group there were 44/112 (39.3%) 
women with periodontitis. It was noted that the prevalence of 
periodontitis was significantly higher (p < 0.001) in the PTB 
group in comparison to the control group of women deliv-
ered at term (66.1% and 12.5%, respectively). The preva-
lence of gingivitis in the PTB and the FTB group did not 
show a statistically significant difference (p > 0.05). 
Analysis of the periodontal status and the secretory sta-
tus showed that there were only 11.4% of non-secretors in 
the group with a healthy periodontium, while in the group 
with periodontitis there were 31.8% of non-secretors which 
was a statistically significant difference (Table 2). 
At baseline, there was no difference between number of 
preterm and term birth subjects according to their secretory 
status (Table 1). However, there was significantly greater 
number (83.3%) of non-secretors preterm birth subjects with 
periodontitis compared to other periodontal disease catego-
ries. In the PTB non-secretors mothers there were no subjects 
with healthy periodontium. Also, full term birth secretors had 
the highest number of subjects (61.4%) with healthy perio-
dontium (p < 0.001) (Table 3). 
When we compared inflammation markers in plasma of 
women who gave preterm birth with women with term birth 
we found significantly higher IL-1ß and PGE2 values in 
plasma of the preterm birth group compared to the FTB 
group. Differences in other parameters in blood, as well as in 
saliva did not reach statistical significance (Table 4). 
According to Spearman’s correlation, in the PTB group 
there was a significant association between salivary levels of 
PGE2 and IL-1ß (R = 0.416, p = 0.017). The significant neg-
ative/inverse correlation was identified between plasma con-
centrations of IL-1ß and PGE2 (R = -0.592, p < 0.001) in the 
PTB group. These correlations were not found in women 
who delivered at term. In the FTB group there were signifi-
cant correlation between salivary and plasma levels of PGE2 
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and maternal age (R = 0.428, p = 0.0009 and R = -0.289, 
p = 0.03, respectively) (Table 5). 
 
Table 5 
Correlation of laboratory parameters in the PTB  
and FTB groups 
Parameters 
PTB 
(R, p) 
FTB 
(R, p) 
sal IL-1b – sal PGE2 
R = 0.416 
p = 0.017 
R = 0.336 
p = 0.09 
pl IL-1b – pl PGE2 
R = -0.592 
p < 0.001 
R = 0.138 
p = 0.48 
sal PGE2 – Age 
R = 0.131 
p = 0.34 
R = 0.428 
p = 0.0009 
pl PGE2 – Age 
R = -0.265 
p = 0.06 
R = -0.289 
p = 0.03 
R – Spearman’s correlation coefficient; PTB – preterm 
birth; FTB – full term birth; sal IL-b – saliva interleukin-1b; 
pl IL-1b – plasma interleukin-1b; sal PGE2 – saliva 
prostaglandine E2; pl PGE2 – plasma prostaglandine E2 
 
At baseline, the mean IL-1ß and PGE2 values in the 
two subsets of patients (secretors and non-secretors) were not 
significantly different (Table 6). However, mean IL-1ß level 
in the non-secretor PTB subgroup with periodontitis was sig-
nificantly higher than in other groups (p < 0.001) (Figure 1). 
 
 
Fig. 1 – Quantitative comparison of median blood 
interleukin-1b (IL-1b) concentration in the study group 
with periodontitis according to birth term and secretor 
status. 
*,**p < 0.05, 0.01, respectively vs. preterm non-secretor 
group; ††p < 0.01 vs. preterm secretor group according to 
Kruskal-Wallis and subsequent Mann-Whitney U test [the 
box represents the first and third quartiles (rectangular 
boxes); the line within the box is the median, and vertical 
bars show the 95% confidence interval].  
Values obtained from the preterm birth (PTB) non-secretor 
group differed significantly from other groups at level p < 0.01. 
Table 6 
Inflammation markers and basic hematological parameters in subgroups according to the secretory status 
Parameter Non-secretor Secretor p 
Age (years), median (range) 35 (33–37) 29.5 (23–31) ns 
IL-1ß, sal, pg/mL 11.203 (10.834–11953) 10.598 (5.690–11.953) ns 
IL-1ß, pl, pg/mL 0.0149 (0.0126–0.0173) 0.0126 (0.0089–0.0137) 0.081 
PGE2.sal, pg/mL 506 (279–733) 327 (62–514) ns 
PGE2, pl, pg/mL 454 (107–800) 1117 (142–1433) ns 
hsCRP, pl, mg/L 22.6 (8.4–46.7) 19.0 (7.3–40.6) ns 
WBC ×109/L 12.5 (9.8–15.2) 16.0 (13.4–19.1) ns 
Hb, g/L 104.8 (95.6–114.0) 111.5 (98.0–123.2) ns 
Plt ×109/L 183 (162–204) 220 (204–279) 0.040 
Note: Results are expressed as medians (25th – 75th percentile); sal – saliva; pl – plasma, WBC – white blood cells; Hb – 
hemoglobin; Plt – platelets; IL 1β – interleukin-1β; hsCRP – high sensitivity C-reactive protein; ns – non significant. 
 
 
Discussion 
Consistent with the hypothesis, we found an increased 
amount of IL1-ß and PGE2 in plasma samples obtained from 
non-secretor preterm delivery women. In addition, there was 
a strong correlation between IL1-ß and PGE2 levels in the 
PTB group compared with the control (FTB) subjects. These 
data support the hypothesis that non-secretor phenotype and 
periodontitis are at least in part responsible for pathogenesis 
of PTB and the probability of negative impact of non-
secretory status cannot be ignored. 
There are various risk factors for preterm birth, out of 
which a previous preterm birth is one of the most important 
(odds ratio 4.5–7.1). This risk factor likely reflects persistent 
genetic and epigenetic components. Nullparity and prior ce-
sarean birth are important risk factors for spontaneous preterm 
birth, but with small associations (odds ratio 1.4–2.4). The gen-
der of the unborn baby also seems to play a role in the process of 
being born prematurely with low risk odds ratio 22.  
Numerous cohort/cross-sectional studies have been 
shown more and less strong association between PTB and 
periodontitis 23, 24. 
There are a few proposed pathways by which periodon-
titis might affect pre-term birth 25: 1) directly when perio-
pathogens invade the fetal-placental unit subsequently stimu-
lating local inflammation; 2) indirectly when inflammatory 
mediators circulate from periodontal burden and synergisti-
cally increase local inflammation; 3) by fetal inflammatory re-
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sponse to mother’s oral pathogens 26; 4) by mother’s enhanced 
antigraft response 27; 5) genetically, by heritable factors 28. 
Periodontitis was diagnosed in 66.1% of women in the 
PTB group. Similar to our findings Dörtbudak et al. 29 have 
reported that periodontitis was diagnosed in 20% of normal 
cases and in 83% of preterm birth ones. These differences 
could be attributed partially to inconsistent definitions of per-
iodontal disease and different definitions of adverse preg-
nancy outcomes. The data of Jarjoura et al. 30 on 83 PTB 
cases and 120 controls support the notion that periodontitis is 
independently associated with PTB and low birth weight. 
The representation of periodontitis in both groups of 
our patients was 39.3% which is in accordance with data pre-
sented by Lieff et al. 31 who found that in the population of 
pregnant women there were around 40% cases of periodontitis. 
However, some cohort and case-control studies did not 
find a significant association between PTB and periodontitis. 
In the prospective study of 273 women performed by Soucy-
Giguère et al. 32 there was no significant association between 
disease of the periodontium and preterm birth but the study 
could not exclude an association between periodontal disease 
and intra-amniotic inflammation. 
Preterm birth, as well as periodontitis, is characterized 
by increased levels of inflammatory markers and among 
them IL-1ß and PGE2 4, 15. 
IL-1ß is a pro-inflammatory cytokine and is expressed 
by many cells including macrophage, natural killer cell (NK) 
cells, monocytes, and neutrophils. It belongs to the IL-1 fam-
ily cluster that includes IL-1a, and IL1-RN genes. IL-1α and 
IL-1ß participate in the regulation of immune response, in-
flammatory reactions, and haematopoiesis. During systemic 
inflammation IL-1 induction in the hypothalamus may regu-
late neuroendocrine functions. The inactive precursor IL1-ß 
has to be processed into mature bioactive form of IL1-ß and 
is usually proteolitically mediated by inflammatory cysteine 
protease caspase-1 33. IL-1ß is one of cytokines in the in-
flammatory cascade resulting in increased production of cy-
clooxygenase-2 (COX-2) and prostaglandins 10, 33. Pros-
taglandins act as long-term mediators of inflammation. IL-1ß 
and PGE2 are involved in biochemical processes in inflam-
mation along with delivery 10, 11. 
Spontaneous delivery at term is characterized by the 
expression of inflammasome components, which may par-
ticipate in the activation of caspase-1 and lead to the cleav-
age and release of mature IL-1β by the chorio-amniotic 
membranes. These results support the participation of the in-
flammasome in the mechanisms responsible for spontaneous 
parturition at term 34. IL-1ß will activate an inflammatory 
cascade that leads to increased concentrations of PGE2 that 
are required for onset of delivery. Prostaglandins are the 
most effective mediators for cervical dilatation in women 
and stimulation of labor. In the myometrium prostaglandins 
contribute to increased uterine contractions and in cervix 
cause degradation of the extracellular matrix resulting in ef-
facement and dilatation. PGE2 has been shown to be a key 
step for the activation of labor 33. 
Intrauterine infection induces an intra-amniotic inflam-
matory response involving the activation of a number of cy-
tokines among them IL-1ß and PGE2 which, in turn, may 
trigger preterm contractions, cervical ripening and rupture of 
the membranes, and induce PTB . Zhumakanovaet al. 35 re-
ported that increasing of level IL-1β, IL- 6 and TNF-α in se-
rum during pregnancy can be used as a nonspecific marker in 
women at risk of preterm birth. 
IL-1ß and PGE2 are increased in infections of the pe-
riodontium tissue. Many authors have shown that salivary 
IL-1b levels in subjects with periodontitis were significantly 
greater than those detected in healthy controls. Studies per-
formed by Kinney et al. 36, and Rathnayake et al. 15, showed 
that levels of IL-1ß correlated with periodontium status. 
Moreover, salivary IL-1b of IL1-ß correlated significantly 
with clinical degree of periodontal inflammation. Certain 
number of research papers show that in patients with perio-
dontitis there is a faster deterioration and rejection of al-
lografts 23. 
It has been demonstrated that production of IL-1ß and 
prostaglandins is increased during rejection and that these 
molecules are able to interfere with graft function 37.  
Published data has shown that IL-1ß enhances the host 
antigraft adaptive response and suggests that IL1-ß may have 
an inherited condition that causes a hyperactivity, which in 
turn may be responsible for PTB 38. 
Vamvakopoulos et al. 39 have demonstrated an associa-
tion between IL-1ß and chronic rejection at the genetic level 
in heart graft recipients. The risk of rejection was 20-fold in-
creased in patients with both the IL-1ß (π3953) C allele and 
the IL1RN1 allele. 
Medawar 40 first posed the theory of the fetus-as-
allograft nearly 60 years ago explaining the normal course of 
pregnancy by maternal-fetal interface, antigenic inertness of 
the fetus and maternal immune tolerance of foreign tissue. 
That tolerance is compromised in PTB. 
Many authors reported that levels of IL-1ß, IL-6 and 
PGE2 in the blood samples were higher in the preterm deliv-
ery women than in the healthy control group and that IL-1ß 
and PGE2 levels in maternal blood were higher among those 
with severe disease of the periodontium in the PTD group. 
According to Kedzierska-Markowicz et al. 41 the level of IL-
1β concentration is an independent predictor of preterm de-
livery in patients with threatened preterm labor. 
Consistently with the reported results, in our study 
groups plasma levels of IL-1ß and PGE2 were significantly 
higher in the PTB group in comparison to the FTB group.  
Differences in plasma levels of C-reactive protein 
(CRP) between the PTB patients and the FTB ones did not 
reach statistical significance. This data is in accordance with 
results of Michalowicz et al. 42 who have suggested that in 
pregnant women levels of CRP were not associated with in-
fant birth weight or a risk for preterm birth. 
PGE2 level in saliva of PTB mothers showed a signifi-
cant positive correlation with IL-1ß in saliva, while plasma 
level of PGE2 showed a significant negative correlation to 
the plasma level of IL-1ß. It may be related to the fact that 
the half-life of IL-1ß is very short (3–4 h), therefore it will 
show a positive correlation only if tested on the place of its 
secretion and not in plasma where it is distant from the in-
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flammatory lesion. Here the correlation becomes negative 
because PGE2 is a long-term activator of the inflammatory 
pathway and it remains high even after its descend in plasma, 
but the levels of IL-1ß decrease due to its short half-life 43.  
Higher levels of IL-1ß and PGE2 in the PTB group 
could be explained by the effect of inflammation in the peri-
odontal tissue, hyperactive IL-1ß 36, reaction of the rejection 
of allograft 23, 39 or hereditary genetic factors 28, 37. 
The recognition that heritable factors play a role in 
PTB 37 is compatible with the notion that extent of periodon-
titis is influenced by secretory status which is to a large ex-
tent inherited and stable 17, 28. 
Secretory status of an individual is genetically deter-
mined by a pair of allomorphic genes: Se and se with Se 
dominant over se. Approximately 80% of the population has 
the secretor (Se) gene 18. 
In secretors salivary blood group antigens agglutinate 
oral pathogens and thus enable multiple functions of saliva 
such as rinsing, bacterial clearance and antimicrobial de-
fense 19. In non-secretors there are no soluble blood group 
substances, oral pathogens recognize histo-blood group anti-
gens on cells surface as attachment factors, form polymicro-
bial gingival/subgingival biofilm, and cause gingival infec-
tion and induction of periodontitis resulting in an increased 
level of TNF-alpha, IL-1ß, IL-6, and PGE2 10, 15, 18. 
Blood group oligosaccharide structures are also impor-
tant for blastocyst adhesion and resistance to microbial inva-
sion. Recent studies suggest intrauterine selection against 
non-secretor embryo carried by a secretor mother. This data 
could have practical importance in assessing the risk of infer-
tility and success of assisted reproductive techniques 44. 
Furthermore, oligosaccharides, glycans, found in the 
breast milk of secretor mothers protect newborns from path-
ogens and play important role in development of the neonatal 
immune system. In the preterm infant they show protective 
effect against gut immaturity. Low salivary blood group oli-
gosaccharides were associated with 10-fold increased odds 
of necrotizing enterocolitis deaths in newborns 45.  
According to literature data it is conceivable that non-
secretors with a lower level of iso-antibodies and immu-
noglobulins may have a lower resistance to infection and 
thereafter higher rate of periodontitis 19. Results of Rocha et 
al. 16 suggest an active role of mucin glycoproteins in the in-
nate immune regulation of periodontal bacterial colonization 
and disease progression. Tabasum and Nayak 46 reported 
22.2% non-secretors in the chronic periodontitis group. The 
higher results in our group could be attributed to placental 
hormones that might affect the clinical and biological fea-
tures of periodontal infections during pregnancy 7, 9. 
Despite much accumulated knowledge on individual etio-
logical factors, the interactions among risk factors and the 
pathophysiology of preterm birth remain unclear and there is no 
biologic explanation for 2/3 of all preterm births 22. 
Conclusion 
Afore mentioned risk factors are surely a surrogate for ge-
netic and epigenetic causes of preterm birth, and support the 
need for additional research into the biology of human parturi-
tion. The etiology of spontaneous PTB is still unknown because 
PTB is a complex syndrome with different co-factors, involving 
a complex interaction between genetic, immunological and en-
vironmental factors. We believe that the identification of ge-
nomic and proteomic markers may represent an added value in 
the further investigation of the association among periodontitis, 
secretory status and adverse pregnancy outcomes. A randomized 
clinical trial will be necessary to appropriately test our hypothe-
sis and conclude whether non-secretory status have impact on 
adverse pregnancy outcome. 
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